We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$104B
AUM Growth
+$6.58B
Cap. Flow
-$453M
Cap. Flow %
-0.43%
Top 10 Hldgs %
10.66%
Holding
2,865
New
128
Increased
1,119
Reduced
1,402
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Industrials 13.85%
3 Financials 12.11%
4 Consumer Discretionary 11.36%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALCO icon
2601
Alico
ALCO
$283M
$78K ﹤0.01%
+2,190
New +$69.2K
CRK icon
2602
Comstock Resources
CRK
$3.94B
$78K ﹤0.01%
11,719
-3,253,340
-100% -$18.7M
MMAT
2603
DELISTED
Meta Materials Inc. Common Stock
MMAT
$78K ﹤0.01%
104
-1
-1% -$558
IEC
2604
DELISTED
IEC Electronics Corp.
IEC
$78K ﹤0.01%
+7,438
New +$84.5K
SMSI icon
2605
Smith Micro Software
SMSI
$16.2M
$77K ﹤0.01%
370
-12
-3% -$2.57K
IVAC
2606
DELISTED
Intevac Inc
IVAC
$77K ﹤0.01%
11,495
+1,505
+15% +$9.78K
NEXT icon
2607
NextDecade
NEXT
$1.78B
$73K ﹤0.01%
17,715
-299
-2% -$843
ISEE
2608
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$73K ﹤0.01%
11,520
-1,221
-10% -$7.88K
ACNT icon
2609
Ascent Industries
ACNT
$141M
$72K ﹤0.01%
7,217
+547
+8% +$5.41K
IMDX
2610
Insight Molecular Diagnostics
IMDX
$156M
$72K ﹤0.01%
630
-37
-6% -$3.61K
ORC
2611
Orchid Island Capital
ORC
$1.31B
$72K ﹤0.01%
2,762
-88
-3% -$2.44K
TCRT icon
2612
Alaunos Therapeutics
TCRT
$4.86M
$72K ﹤0.01%
181
-3
-2% -$1.4K
PNNT
2613
Pennant Park Investment Corp
PNNT
$241M
$71K ﹤0.01%
10,564
-329
-3% -$2.16K
LCTX icon
2614
Lineage Cell Therapeutics
LCTX
$278M
$70K ﹤0.01%
24,527
+1,133
+5% +$2.93K
BELFB
2615
Bel Fuse Inc Class B
BELFB
$4.21B
$69K ﹤0.01%
4,787
-1,083
-18% -$17.8K
ARLO icon
2616
Arlo Technologies
ARLO
$1.65B
$68K ﹤0.01%
10,118
-345
-3% -$2.25K
DENN
2617
DELISTED
Denny's
DENN
$68K ﹤0.01%
4,150
-13,209
-76% -$231K
RRD
2618
DELISTED
RR Donnelley & Sons Co.
RRD
$67K ﹤0.01%
10,695
-210
-2% -$1.15K
CMO
2619
DELISTED
Capstead Mortgage Corp.
CMO
$67K ﹤0.01%
10,836
-171
-2% -$1.1K
ALOT icon
2620
AstroNova
ALOT
$227M
$66K ﹤0.01%
4,730
-6,270
-57% -$96K
ODC icon
2621
Oil-Dri
ODC
$1.34B
$66K ﹤0.01%
+3,874
New +$68.7K
GERN icon
2622
Geron
GERN
$949M
$65K ﹤0.01%
46,182
-728
-2% -$1.06K
TXMD icon
2623
TherapeuticsMD
TXMD
$24M
$65K ﹤0.01%
1,090
-44
-4% -$2.67K
EDUC icon
2624
Educational Development Corp
EDUC
$11.8M
$64K ﹤0.01%
+5,165
New +$79.4K
LAB icon
2625
Standard BioTools
LAB
$314M
$63K ﹤0.01%
10,159
-257
-2% -$1.37K

Similar funds

Victory Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Victory Capital Management held 2,865 positions worth $104B, up 6.7% from $97.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Victory Capital Management's Q2 2021 filing shows 128 new, 1,119 increased, 1,402 reduced and 129 closed positions. Its largest new stake was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M. The largest sale was Darden Restaurants, an estimated $302M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q2 2021 buy was iShares Core S&P Mid-Cap ETF: 6,251,880 shares worth $336M.
  • Victory Capital Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $1.28B increase.
  • Victory Capital Management's biggest Q2 2021 reduction was Darden Restaurants, cutting an estimated $302M.
  • Victory Capital Management fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $245M.
  • Victory Capital Management's ten largest holdings make up 11% of its $104B portfolio in Q2 2021.
  • Victory Capital Management opened 128 new positions and closed 129 in Q2 2021.
  • Victory Capital Management's portfolio value rose 6.7% quarter-over-quarter to $104B.

Based on Victory Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.